Current treatment options for patients with initially unresectable isolated colorectal liver metastases

被引:10
|
作者
Kanat, Ozkan [1 ]
机构
[1] Uludag Univ, Fac Med, Dept Med Oncol, TR-16059 Gorukle, Bursa, Turkey
来源
WORLD JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 7卷 / 01期
关键词
Colorectal cancer; Conversion therapy; Liver metastases; Targeted therapy; Hepatic arterial infusion;
D O I
10.5306/wjco.v7.i1.9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The development of liver metastases is a common clinical entity in the clinical course of colorectal cancer. For patients with isolated liver involvement, surgical resection is the only treatment that can provide a chance of prolonged survival and cure. However, most of these patients are not initially eligible for the surgery. Selected patients with initially considered to have unresectable disease may become resectable after systemic (chemotherapy +/- biological therapy) and loco-regional treatment modalities including hepatic arterial infusion. Patients who have colorectal liver metastases ideally should be referred to a multidisciplinary cancer care team in order to identify the most optimal management approach.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [41] Multimodal treatment options for bilobar colorectal liver metastases
    Homayounfar, Kia
    Liersch, Torsten
    Niessner, Martin
    Meller, Johannes
    Lorf, Thomas
    Becker, Heinz
    Ghadimi, B. Michael
    LANGENBECKS ARCHIVES OF SURGERY, 2010, 395 (06) : 633 - 641
  • [42] Neoadjuvant treatment of unresectable liver metastases from colorectal cancer
    Chua, Yu Jo
    Cunningham, David
    CLINICAL COLORECTAL CANCER, 2006, 5 (06) : 405 - 412
  • [43] Chemotherapy and target therapy as neo-adjuvant approach for initially unresectable colorectal liver metastases
    Rossi, Luigi
    Zullo, Angelo
    Zoratto, Federica
    Papa, Anselmo
    Strudel, Martina
    Colonna, Maria
    Tomao, Silverio
    ONCOLOGY REVIEWS, 2012, 6 (01) : 45 - 50
  • [44] FOLFOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer patients with unresectable liver metastases
    Antoniotti, Carlotta
    Vetere, Guglielmo
    Cremolini, Chiara
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (18)
  • [45] United Kingdom criteria for liver transplantation in the setting of isolated unresectable colorectal liver metastases
    Murphy, Jamie
    Prasad, Raj
    Menon, Krishna
    COLORECTAL DISEASE, 2023, 25 (03) : 489 - 494
  • [46] Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases
    Chen, Zhi-Gang
    Ji, Xiao-Meng
    Xu, Yu-Xia
    Fong, William Pat
    Liu, Xiao-Yun
    Liang, Jie-Ying
    Tan, Qiong
    Wen, Lei
    Cai, Yan-Yu
    Wang, De-Shen
    Li, Yu-Hong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [47] Combined quantitative and radiomics model can predict outcomes in patients with initially unresectable colorectal liver metastases treated with chemotherapy
    Cannella, Roberto
    ABDOMINAL RADIOLOGY, 2025, 50 (02) : 1051 - 1053
  • [48] Impact of FOLFOXIRI plus bevacizumab on resectability and survival in patients with initially unresectable liver metastases from colorectal cancer.
    Shimada, M.
    Nishioka, M.
    Hanaoka, J.
    Mori, H.
    Ikemoto, T.
    Imura, S.
    Morine, Y.
    Utsunomiya, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [49] Cost-effectiveness analysis of hepatic resection after chemotherapy in the management of patients with initially unresectable colorectal liver metastases
    Hayashi, N.
    Satoh, N.
    Chikamoto, A.
    Ikeda, O.
    Horino, K.
    Watanabe, M.
    Ishiko, T.
    Takamori, H.
    Beppu, T.
    Baba, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Impact of FOLFOXIRI regimen on early "conversion" and long-term outcome in patients with initially unresectable colorectal liver metastases
    Shimada, Mitsuo
    Morine, Yuji
    Imura, Satoru
    Ikemoto, Tetsuya
    Arakawa, Yusuke
    Iwahashi, Shuichi
    Saito, Yu
    Yamada, Shinichiro
    Higashijima, Jun
    Takasu, Chie
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)